**Excerpt:**
*”The FDA has approved Precision Neuroscience’s groundbreaking Layer 7 Cortical Interface, a minimally invasive brain implant designed to help patients with severe paralysis. Featuring 1,024 electrodes that sit on the brain’s surface, the device marks a major leap in neurotechnology—and positions Precision as a formidable competitor to Neuralink. With successful trials in 37 patients and plans for a 2026 commercial launch, this innovation brings hope for restoring speech and movement. As the BCI race heats up, Precision’s research-driven approach and $155 million in funding signal a promising future for life-changing medical breakthroughs.”*
This excerpt captures the article’s key points concisely while maintaining engagement and clarity. Let me know if you’d like any refinements!
